Spots Global Cancer Trial Database for therapy
Every month we try and update this database with for therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer | NCT03204734 | Breast Cancer | Capecitabine endocrine thera... | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
Mood and Nutrition Interventions in Polycystic Ovary Syndrome | NCT01899001 | Polycystic Ovar... | Cognitive Behav... Nutrition Couns... | 18 Years - 45 Years | University of Pennsylvania | |
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma | NCT02278315 | Multiple Myelom... | I-131-CLR1404 dexamethasone I-131-CLR1404 | 18 Years - | Cellectar Biosciences, Inc. | |
Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment | NCT00928603 | Prostate Cancer | Focal Cryoablat... | 18 Years - 76 Years | Università Vita-Salute San Raffaele | |
Risk Factors for Residual Neoplasia After Endoscopic Mucosal Resection | NCT01478919 | Colorectal Canc... | 18 Years - | Vitkovice Hospital | ||
Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia | NCT00832234 | Waldenstroms Ma... | Bortezomib, Dex... | 18 Years - | Stichting European Myeloma Network | |
Trial of Endoscopic Ultrasound (EUS) - Guided Celiac Plexus Neurolysis | NCT00974948 | Inoperable, Pai... | EUS-guided celi... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
NAC in CC Resistant PCOS After LOD | NCT02775734 | Clomiphene Citr... | N-acetyl-cystei... Clomiphene citr... | 18 Years - 35 Years | Ain Shams University | |
Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer | NCT00182728 | Breast Cancer | surgery therapy radiation thera... | 48 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma | NCT01438450 | Hepatocellular ... | Oral Supportive | 12 Years - 70 Years | All India Institute of Medical Sciences, New Delhi | |
Creating Meaning Following Cancer: An Intervention to Improve Existential and Global Quality of Life | NCT01141933 | Non-metastatic ... Adjustment Diso... | Cognitive-exist... Usual care | 18 Years - | CHU de Quebec-Universite Laval | |
Creating Meaning Following Cancer: An Intervention to Improve Existential and Global Quality of Life | NCT01141933 | Non-metastatic ... Adjustment Diso... | Cognitive-exist... Usual care | 18 Years - | CHU de Quebec-Universite Laval | |
Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer | NCT00145743 | Breast Neoplasm... | physio,pain,psy... | 18 Years - | Tumor Center Regensburg | |
Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age | NCT03177863 | CIN2 Therapy | Expectancy | 25 Years - 30 Years | Sahlgrenska University Hospital, Sweden | |
Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL | NCT06289959 | Lymphoma, Large... | cfDNA | 18 Years - | Second Affiliated Hospital of Soochow University | |
Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis | NCT01242436 | Ovarian Cancer Peritoneal Meta... | intravenous con... | - | Universitaire Ziekenhuizen KU Leuven | |
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00628238 | Chronic Lymphoc... CLL Untreated Front-line First-Line Initial Therapy | Lenalidomide an... Lenalidomide an... | - | Chronic Lymphocytic Leukemia Research Consortium | |
Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis | NCT01242436 | Ovarian Cancer Peritoneal Meta... | intravenous con... | - | Universitaire Ziekenhuizen KU Leuven | |
C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma | NCT01530269 | Prostate Cancer Prostate Adenoc... | C11-Sodium Acet... | 18 Years - 90 Years | Phoenix Molecular Imaging | |
Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients. | NCT02718391 | Malignant Melan... Adjuvant Drug T... Vaccin Therapy | Autologous Dend... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
Effect of Guided Imagery for Radiotherapy-Related Distress in Patients With Head and Neck Cancer | NCT03662698 | Head and Neck C... | Guided Imagery Treatment as Us... | 18 Years - 100 Years | University of Colorado, Denver | |
Mid-line Excision Versus Karydakis Operation for Pilonidal Sinus | NCT00412659 | Pilonidal Sinus | Surgery for pil... Surgery for pil... | 18 Years - | Umeå University | |
Pre-operative Contrast Enhanced CT to Improve Delineation of the Tumorbed in Radiotherapy for Breast Cancer. | NCT00721058 | Breast Cancer | CT-scan | 18 Years - | Maastricht Radiation Oncology | |
Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer | NCT03204734 | Breast Cancer | Capecitabine endocrine thera... | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00628238 | Chronic Lymphoc... CLL Untreated Front-line First-Line Initial Therapy | Lenalidomide an... Lenalidomide an... | - | Chronic Lymphocytic Leukemia Research Consortium | |
Implementation of Quality of Life Diagnostics and Therapy | NCT00141635 | Breast Neoplasm... | physio,pain,psy... | 18 Years - | Tumor Center Regensburg | |
NAC in CC Resistant PCOS After LOD | NCT02775734 | Clomiphene Citr... | N-acetyl-cystei... Clomiphene citr... | 18 Years - 35 Years | Ain Shams University | |
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors | NCT04683939 | Solid Tumor Gastric Cancer Gastroesophagea... Esophageal Aden... Pancreatic Canc... Biliary Tract C... Cholangiocarcin... Metastatic Canc... | BNT141 Nab-paclitaxel Gemcitabine | 18 Years - | BioNTech SE | |
A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins | NCT01929993 | Cervical Intrae... | SWETZ LLETZ cone | - | Oswaldo Cruz Foundation | |
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression | NCT00718770 | Thyroid Cancer | Bexarotene | 18 Years - | University of Colorado, Denver | |
Fosamax for Childhood Cancer Survivors | NCT00391404 | Osteoporosis | Alendronate Placebo | 15 Years - | Chinese University of Hong Kong | |
A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep) | NCT02597868 | Breast Cancer | Capecitabine endocrine thera... | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer | NCT00182728 | Breast Cancer | surgery therapy radiation thera... | 48 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | NCT00001839 | Hematologic Dis... Myelodysplastic... | Antithymocyte g... Cyclosporine | - | National Institutes of Health Clinical Center (CC) | |
The Efficacy of Kinesio Taping on Lymphedema Following Head and Neck Cancer Therapy | NCT04691310 | Lymphedema Head and Neck C... Kinesio Taping Therapy | Kinesio Tex Gol... | 18 Years - 70 Years | Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization | |
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | NCT00001839 | Hematologic Dis... Myelodysplastic... | Antithymocyte g... Cyclosporine | - | National Institutes of Health Clinical Center (CC) | |
Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy | NCT00671645 | Rectal Cancer | capecitabine, b... | 18 Years - 80 Years | Austrian Breast & Colorectal Cancer Study Group | |
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | NCT00001839 | Hematologic Dis... Myelodysplastic... | Antithymocyte g... Cyclosporine | - | National Institutes of Health Clinical Center (CC) | |
Fosamax for Childhood Cancer Survivors | NCT00391404 | Osteoporosis | Alendronate Placebo | 15 Years - | Chinese University of Hong Kong | |
ZD6474 to Treat Advanced Brain Cancer in Patients | NCT00272350 | Recurrent High-... Progressive Low... Malignant Gliom... | Steroids ZD6474 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Low-Intensity CBT for Gynaecological Cancer Survivors | NCT03553784 | Gynecological C... | Group delivered... | 16 Years - | University of Chester | |
Trial of Individual Psychosocial Interventions for Cancer Patients | NCT01323309 | Advanced Solid ... | Individual Mean... standard Indivi... enhanced usual ... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
Pre-operative Contrast Enhanced CT to Improve Delineation of the Tumorbed in Radiotherapy for Breast Cancer. | NCT00721058 | Breast Cancer | CT-scan | 18 Years - | Maastricht Radiation Oncology | |
Mid-line Excision Versus Karydakis Operation for Pilonidal Sinus | NCT00412659 | Pilonidal Sinus | Surgery for pil... Surgery for pil... | 18 Years - | Umeå University | |
Risk Factors for Residual Neoplasia After Endoscopic Mucosal Resection | NCT01478919 | Colorectal Canc... | 18 Years - | Vitkovice Hospital | ||
Enzastaurin to Treat Recurrent Brain Tumor | NCT00108056 | Glioma | Enzastaurin (LY... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma | NCT01097083 | Carcinoma Therapy | Coriolus Versic... | 21 Years - | National University Hospital, Singapore | |
Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly | NCT02845232 | Acute Myeloid L... | Transfusion | 70 Years - | Hospices Civils de Lyon | |
Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain | NCT02455609 | Therapy Pain Management | intrathecal dru... Dexmedetomidine ketamine Bupivacaine | 30 Years - 50 Years | Assiut University | |
Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma | NCT00493402 | Hepatocellular ... | Transarterial c... Transarterial c... Transarterial c... | 18 Years - 75 Years | Sun Yat-sen University | |
Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age | NCT03177863 | CIN2 Therapy | Expectancy | 25 Years - 30 Years | Sahlgrenska University Hospital, Sweden | |
Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer | NCT00696579 | Bladder Cancer | BCG gemcitabine | 18 Years - 75 Years | University Of Perugia | |
Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma | NCT00554905 | Hepatocellular ... Liver Cancer | Radiofrequency ... TACE | 18 Years - 75 Years | Sun Yat-sen University | |
ZD6474 to Treat Advanced Brain Cancer in Patients | NCT00272350 | Recurrent High-... Progressive Low... Malignant Gliom... | Steroids ZD6474 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy | NCT00083551 | Multiple Myelom... | Thalidomide Ara-C BCNU Cisplatin Cytoxan Dexamethasone Doxorubicin Etoposide Filgrastim Recombinant GM-... Interferon-alph... Melphalan Vincristine | 18 Years - 75 Years | University of Arkansas | |
Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations | NCT04189809 | Hepatocellular ... | 18 Years - | University Hospital, Montpellier | ||
Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma | NCT01438450 | Hepatocellular ... | Oral Supportive | 12 Years - 70 Years | All India Institute of Medical Sciences, New Delhi | |
Non-Hodgkin Lymphoma - Observational Epidemiological and Clinical Study (NiHiL) | NCT03199066 | Non Hodgkin Lym... | 18 Years - | Czech Lymphoma Study Group | ||
Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer | NCT00145743 | Breast Neoplasm... | physio,pain,psy... | 18 Years - | Tumor Center Regensburg | |
Time-Restricted Eating to Address Persistent Cancer-Related Fatigue | NCT05256888 | Neoplasms Therapy Fatigue Diet Therapy Time Survivorship Fasting, Interm... | Time-restricted... Healthy lifesty... | 18 Years - | University of Maryland, Baltimore | |
ZD6474 to Treat Advanced Brain Cancer in Patients | NCT00272350 | Recurrent High-... Progressive Low... Malignant Gliom... | Steroids ZD6474 | 18 Years - | National Institutes of Health Clinical Center (CC) |